Cost-effectiveness of screening a population with chronic gastroesophageal reflux

Gastrointestinal Endoscopy

Volumn 57, Issue 3, 2003, Pages 311-318

  Nietert, Paul J ^a   Silverstein, Marc D ^b   Mokhashi, Mahesh S ^b   Kim, Christopher Y ^b   Glenn, Tammy F ^b   Marsi, Vicki A ^b   Hawes, Robert H ^b   Wallace, Michael B ^b  

^a Center for Health Care Research   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHRONIC DISEASE; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING; SQUAMOUS EPITHELIUM;

EID: 0037344291     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.101     Document Type: Article

References (45)

1. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993;270:1320.
2. Antonioli D. The esophagus. In: Henson D, Alobores-Saavdera J, editors. The pathology of incipient neoplasia. Philadelphia: WB Saunders; 1993. p. 64-84.
3. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
4. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993;105:383-8.
5. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
6. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
7. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670-80.
8. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999;94:2043-53.
9. Corley DA, Levin TR, Habel LA, Weiss NS, Buffier PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002;122:633-40.
10. De Gregorio BT, Poorman JC, Katon RM. Peroral ultrathin endoscopy in adult patients. Gastrointest Endosc 1997;45:303-6.
11. Zaman A, Hapke R, Sahagun G, Katon RM. Unsedated peroral endoscopy with a video ultrathin endoscope: patient acceptance, tolerance, and diagnostic accuracy. Am J Gastroenterol 1998;93:1260-3.
12. Zaman A, Hahn M, Hapke R, Knigge K, Fennerty MB, Katon RM. A randomized trial of peroral versus transnasal unsedated endoscopy using an ultrathin videoendoscope. Gastrointest Endosc 1999;49:279-84.
13. Sorbi D, Gostout CJ, Henry J, Lindor KD. Unsedated small-caliber esophagogastroduodenoscopy (EGD) versus conventional EGD: a comparative study. Gastroenterology 1999;117:1301-7.
14. Dumortier J, Ponchon T, Scoazec JY, Moulinier B, Zarka F, Paliard P, et al. Prospective evaluation of transnasal esophagogastroduodenoscopy: feasibility and study on performance and tolerance. Gastrointest Endosc 1999;49:285-91.
15. Craig A, Hanlon J, Dent J, Schoeman M. A comparison of transnasal and transoral endoscopy with small-diameter endoscopes in unsedated patients. Gastrointest Endosc 1999;49:292-6.
16. Dean R, Dua K, Massey B, Berger W, Hogan WJ, Shaker R. A comparative study of unsedated transnasal esophagogastroduodenoscopy and conventional EGD. Gastrointest Endosc 1996;44:422-4.
17. SEER (Surveillance, Epidemiology, and End Results) Cancer Incidence Public-Use Database, 1973-1997: August 1999 Submission. Volume 2000. Bethesda (MD): National Cancer Institute; 2000.
18. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998;36:778-92.
19. Nissen DE. Mosby's drug consult. St. Louis: Mosby; 2002.
20. Drug Topics Red Book. Oradell (NJ): Medical Economics Co; 1999.
21. Schmitt C, Provenzale D, Brazer S, Davis D, Phillips B, Wolfe W. Quality of life in esophageal disorders [abstract]. Gastroenterology 1994;106:A26.
22. Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. Oxford: Oxford University Press; 1996.
23. Williamson WA, Ellis FH, Jr., Gibb SP, Shahian DM, Aretz HT, Heatley GJ, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151:2212-6.
24. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002;13(Suppl 1):S37-40.
25. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
26. Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996;39:574-9.
27. Soni A, Sampliner RE, Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol 2000;95:2086-93.
28. Shaker R. Unsedated trans-nasal pharyngoesophagogastroduodenoscopy (T-EGD): technique. Gastrointest Endosc 1994;40:346-8.
29. Mokhashi M, Glenn T, Jost C, Walace MB, Kim CY, Palesch YY, et al. Can a 3.1 mm stand-alone battery powered esophagoscope screen the esophagus for esophagitis and Barrett's? A prospective blinded comparison with a standard videoendoscope [abstract]. Gastrointest Endosc 2000;51:AB274.
30. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
31. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
32. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
33. Ovaska J, Miettinen M, Kivilaakso E. Adenocarcinoma arising in Barrett's esophagus. Dig Dis Sci 1989;34:1336-9.
34. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012-6.
35. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5.
36. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
37. Wallace M, Van Dam J. Enhanced gastrointestinal diagnosis: light-scattering spectroscopy and optical coherence tomography. Gastrointest Endosc Clin N Am 2000;10:71-80.
38. Wallace MB, Perelman LT, Backman V, Crawford JM, Fitzmaurice M, Seiler M, et al. Endoscopic detection of dysplasia in patients with Barrett's esophagus using light scattering spectroscopy. Gastroenterology 2000;119:677-82.
39. Wallace MB, Kemp JA, Meyer F, Horton K, Reffel A, Christiansen CL, et al. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists. Am J Med 1999;107:214-8.
40. Maule WF. Screening for colorectal cancer by nurse endoscopists. N Engl J Med 1994;330:183-7.
41. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56.
42. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-94.
43. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999;94:2037-42.
44. Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998;93:536-41.
45. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000;95:1669-76.